Financial Information

Our mission is to develop programs for public education, advocacy and support of those affected, as well as research into the prevention, detection, treatment and cure of prostate cancer.

Imagine Canada, the national organization for philanthropy, suggests the percentage spent on Mission be at least 60% in order to be deemed “high performing”.


For the year ended March 31, 2016, 72.2% of all expenditures were directed to programs and services related to
education, awareness and support groups across the country, and funding research into the prevention, detection,
treatment and cure of prostate cancer.

20.5% of all expenditures were directed to launching and implementing events and general fundraising campaigns
with 7.3% spent on general & administration costs, including office and staff costs.
 


Annual Reports
 



 


View 2015/2016 Annual Report
View 2014/2015 Annual Report
View 2013/2014 Annual Report
View 2012/2013 Annual Report
View 2011/2012 Annual Report
View 2009/2010 Annual Report - part 1
View 2009/2010 Annual Report - part 2
View 2008/2009 Annual Report



*In the spirit of fiscal responsibility, PCC did not publish an Annual Report for the 2010/2011 fiscal year. In lieu of a 2010/2011 Annual Report, PCC’s financial statements are provided below. For more information on 2010 funded programs, please visit our research database.

Financial Information

View Prostate Cancer Canada's financial statement for 2016
View Prostate Cancer Canada's financial statement for 2015

View Prostate Cancer Canada's financial statement for 2014
View Prostate Cancer Canada's financial statement for 2013
View Prostate Cancer Canada's financial statement for 2012
View Prostate Cancer Canada's financial statement for 2011
View Prostate Cancer Canada's financial statement for 2010


Follow the link for Prostate Cancer Canada's T3010.

More Information:

 


 




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Rocco Rossi to wrap up successful 5-year tenure as Prostate Cancer Canada CEO

September 7, 2017 - TORONTO, ON - With mixed emotions, longstanding Prostate Cancer Canada (PCC) President and CEO, Rocco Rossi, formally announced today that his time leading the organization will officially come to a close as of December 31, 2017.
More

Mutation in prostate tumours shown to change epigenetic identity, the make-up of DNA

(TORONTO, Canada - Aug 7, 2017) -- Prostate cancer researchers have mapped the impact of an acquired mutation that alters epigenetic identity, the make-up of DNA, in about 50% of patient tumour samples.
More

Movember Foundation and Prostate Cancer Canada team up to turn research into results

July 26, 2017 - TORONTO, ON - Continuing their longstanding tradition of partnering to fund high quality Canadian prostate cancer research, Prostate Cancer Canada (PCC) and The Movember Foundation today announced two new projects with very real potential to make a tangible difference in the lives of men living with aggressive forms of prostate cancer.
More


Click here for news archive